Anne Hege Aamodt
- Ass. Prof., Senior consultant, OUH and NTNU; MD, PhD
- + 47 958 67 270
Project Manger of ECRI - the European Cerebrovascular Research Infrastructure
Anne Hege Aamodt is a Senior Consultant and Senior Researcher at the Department of Neurology, Oslo University Hospital, Rikshospitalet, Oslo, Chair of the Headache and Stroke Research group at Oslo University Hospital and Chair of the Advisory Board at the Norwegian Headache Research Centre at the Norwegian University of Science and Technology, Trondheim, Norway. Her research interests include acute stroke treatment, cryptogenic stroke, cardioembolic stroke and headache including migraine. She has built a large national and international research network in both cerebrovascular diseases and headache. She is the chief investigator of several multi-center trials such as the TenCRAOS, NOR-FIB and NeuroCOVID trials, the national lead of several trials such as the ESCAPE-NEXT, TENSION, PRECIOUS and ENERGY trials, as well as PI of several trials such as CandMig. Her other responsibilities include: Chair of the Membership Committee in the European Stroke Organization (ESO), Chair of the Constitution and Bylaws Committee in the World Federation of Neurology, National Delegate of the Scientific panel for stroke in the European Academy of Neurology, National Deputy in the European Academy of Neurology, National Coordinator of SITS for Norway, Board member of the Independent Research Fund Denmark, Board member of the EAN Coordinating Panel on Diversity, Equity and Inclusion in Neurology, Executive Board member in the Norwegian Vision in Stroke (NorVIS) Network and a representative for the Norwegian Brain Council in the partnership for the Norwegian Brain Health Strategy.
Publications 2024
Elective Direct Current Cardioversion of Atrial Fibrillation: Silent Brain Infarction and Health-Related Quality of Life
Cardiology, 149 (6), 571-579
DOI 10.1159/000540007, PubMed 39025051
Exploring the Impact of Age and Pre-Stroke Modified Rankin Scale in Elderly Thrombectomy: A 15-Year Single-Center Experience
Cerebrovasc Dis Extra, 14 (1), 125-133
DOI 10.1159/000540992, PubMed 39191213
External validation of clinical risk prediction score for elderly treated with endovascular thrombectomy
J Neurol, 271 (9), 5838-5845
DOI 10.1007/s00415-024-12535-6, PubMed 38954035
Cost-effectiveness of endovascular thrombectomy for acute ischemic stroke with established large infarct in Germany: a decision tree and Markov model
J Neurointerv Surg (in press)
DOI 10.1136/jnis-2024-021837, PubMed 38906688
Imaging features for the identification of atrial fibrillation in cryptogenic stroke patients
J Neurol, 271 (8), 5343-5356
DOI 10.1007/s00415-024-12397-y, PubMed 38904781
Antibodies against SARS-CoV-2 spike protein in the cerebrospinal fluid of COVID-19 patients and vaccinated controls: a multicentre study
J Neurol, 272 (1), 60
DOI 10.1007/s00415-024-12769-4, PubMed 39680178
Endovascular thrombectomy for acute ischaemic stroke with established large infarct (TENSION): 12-month outcomes of a multicentre, open-label, randomised trial
Lancet Neurol, 23 (9), 883-892
DOI 10.1016/S1474-4422(24)00278-3, PubMed 39074480
Brain health concerns us all
Tidsskr Nor Laegeforen, 144 (7)
DOI 10.4045/tidsskr.23.0763, PubMed 38832614
Publications 2023
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis
J Neurol, 270 (7), 3315-3328
DOI 10.1007/s00415-023-11768-1, PubMed 37184659
Transient ischemic attack or migraine with aura?
Tidsskr Nor Laegeforen, 143 (15)
DOI 10.4045/tidsskr.23.0225, PubMed 37874053
[Establishing medical truths]
Tidsskr Nor Laegeforen, 143 (5)
DOI 10.4045/tidsskr.23.0173, PubMed 36987899
Decreasing incidence of stroke, ischaemic heart disease and dementia in Norway, 1990-2019, a Global Burden of Disease study: an opportunity
Eur J Neurol, 30 (8), 2267-2277
DOI 10.1111/ene.15836, PubMed 37154405
Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial
Lancet, 402 (10414), 1753-1763
DOI 10.1016/S0140-6736(23)02032-9, PubMed 37837989
Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment
Lancet Reg Health Eur, 36, 100782
DOI 10.1016/j.lanepe.2023.100782, PubMed 38074444
Predictors of outcome after endovascular treatment for tandem occlusions: a single center retrospective analysis
BMC Neurol, 23 (1), 82
DOI 10.1186/s12883-023-03127-4, PubMed 36849925
[A woman in her sixties who no longer recognised what she saw]
Tidsskr Nor Laegeforen, 143 (16)
DOI 10.4045/tidsskr.23.0198, PubMed 37938009
Clinical outcome after thrombectomy in patients with MeVO stroke: importance of clinical and technical factors
J Neurol, 271 (2), 877-886
DOI 10.1007/s00415-023-12025-1, PubMed 37847291
Prediction of underlying atrial fibrillation in patients with a cryptogenic stroke: results from the NOR-FIB Study
J Neurol, 270 (8), 4049-4059
DOI 10.1007/s00415-023-11680-8, PubMed 37162578
Underlying causes of cryptogenic stroke and TIA in the nordic atrial fibrillation and stroke (NOR-FIB) study - the importance of comprehensive clinical evaluation
BMC Neurol, 23 (1), 115
DOI 10.1186/s12883-023-03155-0, PubMed 36944929
Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study
Eur J Neurol, 30 (5), 1352-1363
DOI 10.1111/ene.15746, PubMed 36786305
Publications 2022
Short- and long-term outcome and predictors in an international cohort of patients with neuro-COVID-19
Eur J Neurol, 29 (6), 1663-1684
DOI 10.1111/ene.15293, PubMed 35194889
Comparative features and outcomes of major neurological complications of COVID-19
Eur J Neurol, 30 (2), 413-433
DOI 10.1111/ene.15617, PubMed 36314485
[Mechanical thrombectomy in acute ischaemic stroke]
Tidsskr Nor Laegeforen, 142 (7)
DOI 10.4045/tidsskr.21.0577, PubMed 35510464
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, 611 (7934), 115-123
DOI 10.1038/s41586-022-05165-3, PubMed 36180795
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, 612 (7938), E7
DOI 10.1038/s41586-022-05492-5, PubMed 36376532
Cryptogenic stroke and TIA: Suggested diagnostic approach while waiting for evaluation and treatment guidelines
Acta Neurol Scand, 145 (5), 641-646
DOI 10.1111/ane.13590, PubMed 35146751
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
Eur Stroke J, 8 (1), 148-156
DOI 10.1177/23969873221123122, PubMed 37021182
Atrial fibrillation in cryptogenic stroke and TIA patients in The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Main results
European Stroke Journal, 0 (0), 1-9
DOI 10.1177/23969873221123122, PublikaID 431
Monitoring following acute stroke should be improved
Tidsskr Nor Laegeforen, 142 (14)
DOI 10.4045/tidsskr.22.0401, PubMed 36226425
Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study
J Stroke Cerebrovasc Dis, 32 (1), 106860
DOI 10.1016/j.jstrokecerebrovasdis.2022.106860, PubMed 36403363
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur J Prev Cardiol, 29 (1), 5-115
DOI 10.1093/eurjpc/zwab154, PubMed 34558602
Cerebral Venous Thrombosis
Semin Thromb Hemost, 48 (3), 309-317
DOI 10.1055/s-0042-1742738, PubMed 35170006
Publications 2021
Brain health: Key to health, productivity, and well-being
Alzheimers Dement, 18 (7), 1396-1407
DOI 10.1002/alz.12478, PubMed 34569702
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
N Engl J Med, 384 (22), 2124-2130
DOI 10.1056/NEJMoa2104882, PubMed 33835768
European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines
Eur Stroke J, 6 (3), CXXII-CXXXIV
DOI 10.1177/23969873211024143, PubMed 34746429
Self-administered biofeedback treatment app for pediatric migraine: A randomized pilot study
Brain Behav., 11 (2), e01974
DOI 10.1002/brb3.1974
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Eur Heart J, 42 (34), 3227-3337
DOI 10.1093/eurheartj/ehab484, PubMed 34458905
Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series
Front Neurol, 12, 721146
DOI 10.3389/fneur.2021.721146, PubMed 34393988
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
J Neurol, 268 (10), 3574-3583
DOI 10.1007/s00415-021-10517-6, PubMed 33743046
Brain monitoring in hospitals needs to be strengthened
Tidsskr. Nor. Laegeforen., 141 (15), 1431-1433
Brain monitoring in hospitals needs to be strengthened
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0412, PubMed 34726044
Publications 2020
Simulation Methods in Acute Stroke Treatment: Current State of Affairs and Implications
Stroke, 51 (7), 1978-1982
DOI 10.1161/STROKEAHA.119.026732, PubMed 32568639
[Too little knowledge about blood pressure in cases of ischaemic stroke]
Tidsskr Nor Laegeforen, 140 (9)
DOI 10.4045/tidsskr.20.0323, PubMed 32549003
Too little knowledge of blood pressure in ischemic stroke
Tidsskr. Nor. Laegeforen., 140 (9), 870-871
Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study
Cerebrovasc Dis Extra, 10 (1), 11-20
DOI 10.1159/000504529, PubMed 32028277
Cerebral venous thrombosis after COVID-19
Tidsskr. Nor. Laegeforen., 140 (18), 1911-1913
[Cerebral venous thrombosis after COVID-19]
Tidsskr Nor Laegeforen, 140 (18)
DOI 10.4045/tidsskr.20.0563, PubMed 33322869
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe Covid-19?
Tidsskr. Nor. Laegeforen., 140 (9), 859-860
Do ACE inhibitors and angiotensin receptor antagonists increase the risk of severe COVID-19?
Tidsskr Nor Laegeforen, 140 (9)
DOI 10.4045/tidsskr.20.0411, PubMed 32549022
How does COVID-19 affect the brain?
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0444, PubMed 32602331
Publications 2019
Imaging of Patients with Suspected Large-Vessel Occlusion at Primary Stroke Centers: Available Modalities and a Suggested Approach
AJNR Am J Neuroradiol, 40 (3), 396-400
DOI 10.3174/ajnr.A5971, PubMed 30705072
Persistent postural- perceptual dizziness
Tidsskr. Nor. Laegeforen., 139 (9), 833-836
Persistent postural-perceptual dizziness
Tidsskr Nor Laegeforen, 139 (9)
DOI 10.4045/tidsskr.18.0962, PubMed 31140261
Study of acute dizziness
Tidsskr. Nor. Laegeforen., 139 (9), 828-832
[Assessment in cases of acute dizziness]
Tidsskr Nor Laegeforen, 139 (9)
DOI 10.4045/tidsskr.18.0958, PubMed 31140257
Atrial fibrillation in cryptogenic stroke and transient ischaemic attack - The Nordic Atrial Fibrillation and Stroke (NOR-FIB) Study: Rationale and design
Eur Stroke J, 4 (2), 172-180
DOI 10.1177/2396987319837089, PubMed 31259265
Tenecteplase Versus Alteplase Between 3 and 4.5 Hours in Low National Institutes of Health Stroke Scale
Stroke, 50 (2), 498-500
DOI 10.1161/STROKEAHA.118.024223, PubMed 30602354
Practical management of headache
Tidsskr. Nor. Laegeforen., 139 (7), 617-620
Practical management of headache
Tidsskr Nor Laegeforen, 139 (7)
DOI 10.4045/tidsskr.18.0837, PubMed 30969051
Hjernehelse
In Nevrologi og Nevrokirurgi: fra barn til voksen. (Harbo HF, Helseth E, Rootwelt T, eds.), Fagbokforlaget
PublikaID 430, ISBN 9788245024739
Publications 2018
[Tenecteplase in acute cerebral infarction]
Tidsskr Nor Laegeforen, 138 (1)
DOI 10.4045/tidsskr.17.0992, PubMed 29313604
Tenecteplase in acute ischemic stroke
Tidsskr. Nor. Laegeforen., 138 (1), 22-23
Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack
J Am Heart Assoc, 7 (2)
DOI 10.1161/JAHA.117.006479, PubMed 29330254
Migraine and stroke
Tidsskr Nor Laegeforen, 138 (4)
DOI 10.4045/tidsskr.17.0347, PubMed 29460580
[The correct dosage of mobilisation]
Tidsskr Nor Laegeforen, 138 (17)
DOI 10.4045/tidsskr.18.0769, PubMed 30378404
The right dosage of mobilization
Tidsskr. Nor. Laegeforen., 138 (17), 1590
The indication position of thrombectomy
Tidsskr. Nor. Laegeforen., 138 (17), 1592
[Indications for thrombectomy]
Tidsskr Nor Laegeforen, 138 (17)
DOI 10.4045/tidsskr.18.0771, PubMed 30378416
Publications 2017
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial
Lancet Neurol, 16 (10), 781-788
DOI 10.1016/S1474-4422(17)30253-3, PubMed 28780236
Publications 2016
New anticoagulants in combination with antiplatelet agents
Tidsskr Nor Laegeforen, 136 (18), 1543-1546
DOI 10.4045/tidsskr.15.1356, PubMed 27731598
Publications 2015
Pseudoperipheral palsy: a case of subcortical infarction imitating peripheral neuropathy
BMC Neurol, 15, 151
DOI 10.1186/s12883-015-0409-y, PubMed 26357841
Cerebral foreign body reaction after carotid aneurysm stenting
Interv Neuroradiol, 22 (1), 53-7
DOI 10.1177/1591019915609171, PubMed 26510943
A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS)
BMC Neurol, 15, 110
DOI 10.1186/s12883-015-0359-4, PubMed 26162826
Publications 2014
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke
BMC Neurol, 14, 106
DOI 10.1186/1471-2377-14-106, PubMed 24886064
[Septic embolus]
Tidsskr Nor Laegeforen, 134 (9), 945
DOI 10.4045/tidsskr.13.1656, PubMed 24828721
Publications 2013
Patient selection for intra-arterial cerebral revascularization in acute ischemic stroke
Acta Neurol Scand Suppl (196), 65-8
DOI 10.1111/ane.12052, PubMed 23190294
A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study
Cephalalgia, 34 (7), 523-32
DOI 10.1177/0333102413515348, PubMed 24335848
When every minute counts
Tidsskr Nor Laegeforen, 133 (12-13), 1324
DOI 10.4045/tidsskr.13.0627, PubMed 23817264
[Atrial fibrillation and stroke]
Tidsskr Nor Laegeforen, 133 (14), 1453-7
DOI 10.4045/tidsskr.12.0850, PubMed 23929293
Publications 2012
Stroke and atrial fibrillation
Period. Biol., 114 (3), 277-286
Publications 2010
Headache, migraine and cardiovascular risk factors: the HUNT study
Eur J Neurol, 18 (3), 504-11
DOI 10.1111/j.1468-1331.2010.03199.x, PubMed 20825470
Publications 2009
The validity of questionnaire-based diagnoses: the third Nord-Trøndelag Health Study 2006-2008
J Headache Pain, 11 (1), 67-73
DOI 10.1007/s10194-009-0174-7, PubMed 19946790
Publications 2008
A face-to-face interview of participants in HUNT 3: the impact of the screening question on headache prevalence
J Headache Pain, 9 (5), 289-94
DOI 10.1007/s10194-008-0062-6, PubMed 18690490
Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study
Cephalalgia, 28 (2), 144-51
DOI 10.1111/j.1468-2982.2007.01486.x, PubMed 18197884
Publications 2007
Is headache related to asthma, hay fever, and chronic bronchitis?: the Head-HUNT study
Blackwell, [Oxford?], Bl. 204-212
BIBSYS 070993254
Is headache related to asthma, hay fever, and chronic bronchitis? The Head-HUNT Study
Headache, 47 (2), 204-12
DOI 10.1111/j.1526-4610.2006.00597.x, PubMed 17300360
Headache prevalence related to diabetes mellitus. The Head-HUNT study
Eur J Neurol, 14 (7), 738-44
DOI 10.1111/j.1468-1331.2007.01765.x, PubMed 17594328
Publications 2006
Headache prevalence related to smoking and alcohol use. The Head-HUNT Study
Eur J Neurol, 13 (11), 1233-8
DOI 10.1111/j.1468-1331.2006.01492.x, PubMed 17038038
Prevalence of haemochromatosis gene mutations in Parkinson's disease
J Neurol Neurosurg Psychiatry, 78 (3), 315-7
DOI 10.1136/jnnp.2006.101352, PubMed 17056630
Publications 2004
Headache prevalence related to haemoglobin and ferritin. The HUNT Study
Cephalalgia, 24 (9), 758-62
DOI 10.1111/j.1468-2982.2004.00756.x, PubMed 15315532
Headahce prevalence related to haemoglobin and ferritin: the HUNT study
Blackwell, [Oxford], Bl. 758-762
BIBSYS 050432885
Publications 2001
Complications after LP related to needle type: pencil-point versus Quincke
Acta Neurol Scand, 103 (6), 396-8
DOI 10.1034/j.1600-0404.2001.103006396.x, PubMed 11421853
Publications 1999
Reproducibility of indoor environment characteristics obtained in a walk through questionnaire. A pilot study
Indoor Air, 9 (1), 26-32
DOI 10.1111/j.1600-0668.1999.t01-3-00005.x, PubMed 10195273